secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioRestorative Therapies, Inc. (BRTX)
CIK:        0001505497
Form:       8-K
Filed at:   2025-09-25T23:59:59+00:00
Accession:  0001021771-25-000131
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

BioRestorative Therapies shareholders elect directors, approve stock plan amendment, ratify auditor, okay exec pay
--------------------------------------------------------------------------------

- Elected Francisco Silva (1.59M for) and David Rosa (1.47M for) as Class II directors; ~3.33M broker non-votes.
- Approved amendment to 2021 Stock Incentive Plan boosting authorized shares from 6.85M to 9.85M (1.34M for, 289K against).
- Ratified CBIZ CPAs as independent auditor for FY2025: 4.72M for, 271K against, 4,864 abstentions.
- Advisory vote on executive compensation passed: 1.54M for, 107K against, 19,855 abstentions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1505497/000102177125000131/0001021771-25-000131-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1505497/000102177125000131/brt91825.htm
  HTML page:      https://secwatch.observer/filing/0001021771-25-000131

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer